CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

Bedell Frazier Investment Counselling, LLC's Holding History (CIK: 0001388142)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 7,646 Value ($000) $372 Avg Close $38.70 Range $30.04 - $51.52
Q1 2025
Shares 14,764 Value ($000) $502 Avg Close $42.39 Range $32.96 - $55.88
Q4 2024
Shares 21,113 Value ($000) $831 Avg Close $47.22 Range $38.20 - $59.07
Q3 2024
Shares 26,357 Value ($000) $1,238 Avg Close $50.74 Range $43.42 - $63.68
Q2 2024
Shares 26,139 Value ($000) $1,412 Avg Close $57.84 Range $51.02 - $68.39
Q1 2024
Shares 23,947 Value ($000) $1,632 Avg Close $71.59 Range $58.29 - $91.10
Q4 2023
Shares 23,976 Value ($000) $1,501 Avg Close $55.02 Range $37.55 - $76.97
Q3 2023
Shares 24,587 Value ($000) $1,116 Avg Close $51.65 Range $44.53 - $59.67
Q2 2023
Shares 24,405 Value ($000) $1,370 Avg Close $56.74 Range $43.10 - $72.00
Q1 2023
Shares 27,103 Value ($000) $1,226 Avg Close $48.57 Range $39.88 - $58.50
Q4 2022
Shares 27,662 Value ($000) $1,124 Avg Close $53.05 Range $38.94 - $66.31
Q3 2022
Shares 31,467 Value ($000) $2,056 Avg Close $72.47 Range $60.41 - $86.95
Q2 2022
Shares 34,387 Value ($000) $2,090 Avg Close $58.79 Range $42.51 - $75.42
Q1 2022
Shares 30,105 Value ($000) $1,889 Avg Close $62.79 Range $50.54 - $79.40
Q4 2021
Shares 26,889 Value ($000) $2,038 Avg Close $87.36 Range $67.15 - $112.39
Q3 2021
Shares 25,147 Value ($000) $2,815 Avg Close $125.59 Range $109.63 - $163.00
Q2 2021
Shares 23,636 Value ($000) $3,826 Avg Close $121.62 Range $95.11 - $169.76
Q1 2021
Shares 22,942 Value ($000) $2,795 Avg Close $151.00 Range $100.00 - $220.20
Q4 2020
Shares 17,862 Value ($000) $2,735 Avg Close $118.20 Range $79.31 - $181.42